Give your opinion on a genetically modified medicine for the treatment of Duchenne muscular dystrophy
January 18, 2022
The FPS Public Health and the FAMHP invite you to participate in the public consultation on a clinical trial of the genetically modified medicine SRP-9001 for the treatment of Duchenne muscular dystrophy. The public consultation runs from 17 January 2022 to 16 February 2022.
Source: FAMHP
For each clinical trial application for the use of a genetically modified organism, the government organises a thirty-day public consultation, in accordance with the Royal Decree of 21 February 2005(link is external). As a citizen, you can give your opinion on this clinical trial application with a genetically modified medicine.